| 1 |
34544640 | Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks. | 2021 Nov |
1 |
| 2 |
31162255 | Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid. | 2019 Sep |
1 |
| 3 |
29278583 | Prostate-specific membrane antigen theranostics: therapy with lutetium-177. | 2018 Mar |
1 |
| 4 |
29455299 | Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy. | 2018 Jun |
1 |
| 5 |
29752180 | [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. | 2018 Jun |
1 |
| 6 |
30037209 | Prostate specific membrane antigen: the role in salvage lymph node dissection and radio-ligand therapy. | 2018 Oct |
1 |
| 7 |
25771365 | Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody. | 2016 |
2 |
| 8 |
26586724 | Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues. | 2016 Jan |
1 |
| 9 |
26967720 | Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine. | 2016 May |
3 |